Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4594)
All Articles published online
|
Publishing Process of This Article
|
Jul 24, 2024 (publication date) through May 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Sun HK, Jiang WL, Zhang SL, Xu PC, Wei LM, Liu JB. Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis. World J Clin Oncol 2024; 15(7): 920-935 [PMID: 39071463 DOI: 10.5306/wjco.v15.i7.920] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Sun HK, Jiang WL, Zhang SL, Xu PC, Wei LM, Liu JB. Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis. World J Clin Oncol 2024; 15(7): 920-935 [PMID: 39071463 DOI: 10.5306/wjco.v15.i7.920] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i7/920.htm |
| Number | Citing Articles |
| 1 |
Liudmila G. Zhukova, Tansylu M. Ibragimova, Daria A. Filonenko, Inna P. Ganshina, Irina V. Sorokina, Andrei A. Lazarev, Olga N. Mironenko, Oxana N. Prosianikova. Efficacy of neoadjuvant TCHP regimen with empegfilgrastim in early HER2-positive breast cancer: Final analysis of the DEFENDOR SPECIAL study, HER2+ BC cohort. Journal of Modern Oncology 2026; 28(1): 21 doi: 10.26442/18151434.2026.1.203640
|
| 2 |
Noor Ul Ain, Sara Ishaq, Muhammad Khurrum Islam, Quratulain Badar, Kamran Chaudhry, Tooba Adil, Sudhair Abbas Bangash. Association of Tumor-Infiltrating Lymphocytes (TILs) With Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer. Cureus 2025; doi: 10.7759/cureus.96076
|
| 3 |
Selami Bayram, Ali Murat Tatli, Muharrem Okan Cakir, Mustafa Ozdogan. Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study. Current Oncology 2025; 32(11): 603 doi: 10.3390/curroncol32110603
|
| 4 |
Liangqiang Li, Peidong Yang, Chengye Hong, Debo Chen, Weibin Lian. Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response and prognosis in breast cancer: a multicenter retrospective study based on Chinese population. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15022-x
|